4
Changes in Ownership
IMMUNIC, INC. Filed Acc 0001280776-19-000017
Options or other derivatives
- Chief Scientific Officer, EVP acquired 816,634 shares (grant or award)
- Chief Scientific Officer, EVP returned 583,391 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Ashley Robert A. · Chief Scientific Officer, EVP
Table II: Derivative
7 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-11 | Returned to the company : show line 1 in the form Stock Option (right to buy) | −93,377 | 0 | D |
| 2019-01-11 | Returned to the company : show line 2 in the form Stock Option (right to buy) | −23,344 | 0 | D |
| 2019-01-11 | Returned to the company : show line 3 in the form Stock Option (right to buy) | −241,670 | 0 | D |
| 2019-01-11 | Returned to the company : show line 4 in the form Stock Option (right to buy) | −75,000 | 0 | D |
| 2019-01-11 | Returned to the company : show line 5 in the form Stock Option (right to buy) | −75,000 | 0 | D |
| 2019-01-11 | Returned to the company : show line 6 in the form Stock Option (right to buy) | −75,000 | 0 | D |
| 2019-01-11 | Grant or award : show line 7 in the form Restricted Stock Units | +816,634 | 816,634 | D |
Loading xslF345X03/wf-form4_154752054652794.xml…